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Abstract
To implement effective stewardship in food animal production, it is essential that producers and
veterinarians are aware of preventive interventions to reduce illness in livestock. Systematic
reviews and meta-analyses (SR/MA) provide transparent, replicable, and quality-assessed
overviews. At present, it is unknown how many SR/MA evaluate preventive antibiotic use or
management practices aimed at reducing disease risk in animal agriculture. Further, the quality
of existing reviews is unknown. Our aim was to identify reviews investigating these topics and to
provide an assessment of their quality. Thirty-eight relevant reviews were identified. Quality
assessment was based on the AMSTAR 2 framework for the critical appraisal of systematic
reviews. The quality of most of the reviews captured was classified as critically low (84.2%,
n = 32/38), and only a small percentage of the evaluated reviews did not contain critical weak-
nesses (7.9%, n = 3/38). Particularly, a small number of reviews reported the development of an
a priori protocol (15.8%, n = 6/38), and few reviews stated that key review steps were conducted
in duplicate (study selection/screening: 26.3%, n = 10/38; data extraction: 15.8%, n = 6/38).
The development of high-quality reviews summarizing evidence on approaches to antibiotic
reduction is essential, and thus greater adherence to quality conduct guidelines for synthesis
research is crucial.
Background
Presently, antibiotics are a crucial tool for both the prevention and treatment of diseases in
humans (WHO, 2015) and in animals (FAO, 2016; OIE, 2016). The application of antimicro-
bial drugs, particularly antibiotics, has prompted substantive improvements in health out-
comes since such medicines were introduced 75 years ago (Laxminarayan et al., 2013; FAO,
2016; OIE, 2016). However, there are growing global concerns about antimicrobial resistance
(AMR) and the threat that AMR poses for the continuing efficacy of treatments for many
important infectious diseases (FAO, 2016). In response to this threat, plans to combat AMR
have been developed by major international organizations including the World Health
Organization (WHO) (WHO, 2012, 2015), the Food and Agriculture Organization of the
United Nations (FAO) (FAO, 2016), and the World Organization for Animal Health (OIE)
(OIE, 2016).
Antibiotics are used in livestock production around the world, contributing to the emer-
gence of AMR (WHO, 2012). In modern food animal production systems, antibiotics are
used both for disease prevention and treatment (WHO, 2012, 2015; Laxminarayan et al.,
2013), and may be administered at the group level (WHO, 2012). A major concern is that
the widespread use of antibiotics in animal agriculture will accelerate resistance to important
treatment options for infectious diseases in humans and animals. For those microorganisms
that affect animals, the implications of AMR include increased morbidity and mortality,
reduced animal welfare, and production losses in livestock industries (Laxminarayan et al.,
2013; WHO, 2015).
The WHO, the FAO, the American Veterinary Medical Association (AVMA), the Canadian
Veterinary Medical Association (CVMA), and others call for the reduction of antibiotic use in
food animal production, and for improved antibiotic stewardship in the sector (WHO, 2012;
Laxminarayan et al., 2013; FAO, 2016; CVMA, 2017; AVMA, 2019a). In the context of veter-
inary medicine, this stewardship requires the implementation of preventive management
strategies to reduce both the incidence of infectious diseases as well as the need for antibiotic
treatments while maintaining animal health and welfare (AVMA, 2019a). There are two key
approaches that can be implemented to prevent and control
diseases in food animal production: prophylactic or metaphylactic
applications of antibiotics among at-risk livestock populations
(AVMA, 2019b); and adhering to livestock management practices
to prevent diseases that would otherwise require antibiotic treat-
ments. Preventive uses of antibiotics include applications, usually
in feed or water, to control the spread of a specific pathogen in a
defined group of livestock, as well as routine treatments given to
a group of animals during known times of higher disease risk to
prevent infection (Laxminarayan et al., 2013). Interventions such
as vaccinations, biosecurity, and hygiene best practices may also
reduce infections requiring antibiotic treatment in livestock
(WHO, 2015).
In order to appropriately implement disease prevention
strategies, it is crucial that the animal health, production, and
economic consequences of each approach are rigorously and
scientifically assessed. Systematic reviews, either alone or in com-
bination with statistical meta-analyses, are powerful synthesis
tools that provide researchers, industry groups, government agen-
cies, and clinicians with concise, quality-assessed summaries of
primary research for use in evidence-based decision-making
(Higgins and Green, 2011; Khan et al., 2011; Sargeant and
O’Connor, 2014a). Existing systematic reviews of preventive
antibiotic use and non-antibiotic management practices designed
to prevent disease are a potential source of high-level evidence on
the efficacy of these approaches, and thus these reviews may be
crucially important in livestock management decision-making
aiming to optimize antibiotic use. At present, it is unknown
how many synthesis studies on these topics exist, and the quality
of any such reviews is similarly unknown. Both the quality of the
conduct of a review and the transparency and completeness of
review reporting impact the ability of end-users to judge the rele-
vance and accuracy of the review results and therefore affect the
usefulness of the results for informed decision-making. This
review focuses specifically on an evaluation of the execution of
systematic review and meta-analysis studies. Well-executed
reviews that minimize selection bias and information error give
end-users greater confidence in the review results, and so the
results of reviews that incorporate strategies to reduce or eliminate
sources of bias and error are considered to be at a lower risk of
bias than the results of reviews that fail to address these points
(Sargeant and O’Connor, 2014a).
The purpose of this study was 2-fold: first, to inventory all
systematic reviews and meta-analyses that examine antibiotic
and non-antibiotic approaches to disease prevention in livestock
production published in the last 25 years; and second, to evaluate
the quality of these systematic reviews and meta-analyses using
the AMSTAR-2 tool (Shea et al., 2017), both to determine
whether there are methodological aspects that warrant improve-
ment and to provide an indication of the level of confidence
that end-users should have in the rigor and accuracy of the results
of those existing reviews.
Methods
Eligibility criteria
To be included in the present analysis, a review article had to include
at least one systematic review and/or meta-analysis (as defined by
the review authors) that examined at least one intervention consti-
tuting either preventative antibiotics or management practices
designed to reduce antibiotic use in at least one livestock or poultry
species. Reviews also had to include at least one clinically relevant
outcome: a measure of clinical morbidity, mortality, gross patho-
logical lesions, and/or condemnation at slaughter. Additionally,
reviews were only included if the full text was available in English.
Search and relevance screening
The search and initial relevance screening was conducted as part
of a larger scoping review on synthesis research in animal health,
animal performance, and on-farm food safety over the past 25
years (1995–2018) (Vriezen et al., 2019). A subset of the papers
identified in that study was selected for inclusion in the present
analysis. The search and original screening methods are described
in detail elsewhere (Vriezen et al., 2019), and the complete search
string is available in Supplementary Appendix 1. Briefly, a com-
prehensive search was conducted in three electronic databases
(MEDLINE via PubMed, CAB Direct, and AGRICOLA via
ProQuest) for systematic reviews and/or meta-analyses combined
with search terms related to livestock, companion animals, and
wildlife. Two reviewers independently screened the title and
abstract of each citation identified in the search for publications
that used the terms ‘systematic review’ or ‘meta-analysis’ and
were of relevance to animal health, performance, or on-farm
food safety. The titles and abstracts of all articles that passed
the first screening were subject to data characterization based
on the information provided in the title and abstract, again by
two independent reviewers. Ultimately, 1787 synthesis studies
were included in the scoping review.
For the present analysis, an additional screening process was
applied to the 1787 review articles included in the scoping
study. Two reviewers independently screened each abstract to
determine whether the review targeted one or more livestock or
poultry species, whether the review investigated an intervention
or exposure, whether the review examined at least one health out-
come, and whether the subject matter of the review concerned
either the use of antibiotics designed to reduce disease incidence
and thus future antibiotic use, or non-antibiotic management
practices intending to reduce illness or future antibiotic use.
Full-text articles were obtained for the review articles that passed
this screening round. Two reviewers then independently screened
the full texts to ensure that each article met all of the eligibility
criteria outlined above. All conflicts in either screening round
were resolved by consensus.
All papers that passed the full-text screening were then subject
to data characterization, which was also conducted independently
by two reviewers, and was based on the full texts of the included
reviews. Conflicts were resolved by consensus. The framework for
the analysis of the quality of existing reviews was based on the
AMSTAR 2 tool, which is designed for the critical appraisal of
systematic reviews of healthcare interventions (Shea et al.,
2017). The data screening form was created following the
AMSTAR 2 checklist, with some modifications made by the
authors to adapt the tool for this study. Additional items were
added to the charting form to capture the target commodity
group(s) or livestock species, as well as the interventions and out-
comes that were examined in the review.
Data collection
Data were collected regarding the livestock or poultry commodity
group targeted in the review, as well as the types of interventions
and outcomes assessed in each article. One reviewer (RV) then
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grouped the interventions and outcomes into broad categories,
and another reviewer (JS) verified the categorization. A list of
each of the interventions and outcomes included in each category
is presented in Supplementary Appendix 2.
The first item on the AMSTAR 2 tool requires the review
research question and eligibility criteria for primary study inclu-
sion to follow the PICO/PECO framework. The acronym ‘PICO’
represents the components of a research question that is designed
to evaluate the efficacy of an intervention, namely Population or
Participants (P), Intervention(s) (I)/Exposure(s) (E), Comparison
group(s) (C), and Outcome(s) (O) (EFSA, 2010; Higgins and
Green, 2011). Each of the included reviews was examined to
determine whether the elements of the PICO/PECO acronym
could be identified in the review question, objectives, or eligibility
criteria. In some cases, the comparator group was not explicitly
described in the methods section of the review, but comparison
groups were described and discussed in the results and other sec-
tions of the article; this was judged to be sufficient consideration.
We also recorded whether or not the review authors clearly iden-
tified eligibility criteria for the inclusion of studies in the review,
either through the incorporation of the PICO/PECO elements or
by explicitly specifying alternate criteria. The AMSTAR 2 frame-
work further recommends that reviews identify the timeframe for
follow-up, but this was not assessed in the present study because
follow-up times could differ across outcomes within a single
review.
The second AMSTAR 2 item requires review authors to estab-
lish an a priori protocol and to justify any deviations from that
protocol to ensure that the review did not evolve as literature
was identified, which could create selection bias (Higgins and
Green, 2011). The AMSTAR 2 checklist includes a list of require-
ments that the protocol must meet, and also requires that the
protocol be registered. Review protocols were not obtained and
examined in the current study; the criterion applied in this
study required only that an a priori protocol be specified.
The third AMSTAR 2 item requires review authors to justify
the selection of eligible study designs for inclusion in the review
(i.e. randomized trials, non-randomized trials, or both). As differ-
ent types of study designs may be appropriate for addressing
research questions related to animal health, this item was evalu-
ated based on whether the review authors identified which
study designs were eligible both during the search and data extrac-
tion phases.
The fourth AMSTAR 2 item details the requirements of an
appropriate literature search strategy: at least two databases
must have been searched; the search string or key words used
in the search must be provided; any search restrictions (e.g. lan-
guage) must be justified; grey literature must have been searched,
including contacting experts in the field and searching trial regis-
tries; the reference lists of eligible studies must have been
searched; and the search must have been completed within 2
years of the review. Most of these criteria were evaluated in the
current study, with the exception of the requirement to search
trial registries, since trial registries for studies related to animal
health have only recently been established and are not commonly
used. When evaluating whether or not review authors searched
the bibliographies of included or eligible primary studies, the
criterion was only considered fulfilled if the authors searched
the reference lists of all included studies, as opposed to searching
only one or several bibliographies. It is challenging to assess the
requirement that the search must have been conducted within
24 months of the completion of the review because the date of
completion of any study is not typically reported. The year of
publication is more commonly available, but due to the length
of the submission and review process, this date does not generally
correspond to study completion. Nonetheless, stating the date of
the search in the methods section of the review is useful, as it
informs the reader of the timespan of the studies captured in
the review. Therefore, we recorded whether or not review authors
specified the date of the search as a part of our evaluation of this
AMSTAR 2 item. To meet this particular criterion, authors must
have identified the month and year during which the literature
search was conducted.
The fifth and sixth AMSTAR 2 domains require authors to
conduct study selection and data extraction in duplicate; these
criteria were considered fulfilled if review authors stated that
these steps were conducted independently by at least two
reviewers, or if they were conducted by one reviewer and verified
by a second.
The seventh AMSTAR 2 item requires authors to provide a list
of any studies excluded following the retrieval of full-text articles
and to justify those exclusions. In the present analysis, this condi-
tion was considered partially fulfilled if the review authors listed
the reasons for any exclusions following the full-text screening,
as well as the numbers of studies excluded for each reason. The
criterion was considered fully met if the authors provided a bibli-
ography of those exclusions, as well as a justification for exclusion
for each study in the bibliography.
Item eight on the AMSTAR 2 tool lists all of the elements that
should be presented in review articles for each of the included
primary studies, including the research designs, populations,
interventions, outcomes, comparators, settings, and follow-up
timeframes; according to the AMSTAR 2 framework, each of
these elements must be described ‘in adequate detail’, but little
additional guidance is provided for the assessment of that level
of detail (Shea et al., 2017). Although it is important to describe
these details, we judged that the evaluation of what constitutes an
adequate level of detail for each of these areas would be subjective.
For this criterion, we opted to assess only whether review authors
identified the languages and study designs of the primary studies
included in their review.
The ninth AMSTAR 2 item details the requirements for the risk
of bias assessment for each of the studies included in the review,
with separate requirements for reviews incorporating randomized
and non-randomized control trials. For this item, the present
study evaluated whether a risk of bias assessment was conducted
or if features of bias, such as randomization, were incorporated
into the eligibility criteria, whether the authors identified the tool
used in the risk of bias assessment, and whether the assessment
was conducted in duplicate.
The tenth AMSTAR 2 item, which requires authors to describe
the funding sources of all studies included in the review, was not
assessed in the present study because there is an ongoing debate
as to the relevance of sources of funding as a potential source
of bias (Bero, 2013; Sterne, 2013). Additionally, some of the
bias that might be introduced based on funding sources for indi-
vidual studies might also be captured under the checklist items
devoted to the risk of bias and publication bias assessments that
are applied to the review as a whole.
Item 11 on the AMSTAR 2 checklist focuses on the evaluation
of meta-analytic methods. The criteria used to assess this item
were simplified because several studies reported multiple
meta-analyses with varying levels of detail, and it was not feasible
to evaluate each meta-analysis separately. Thus, the criteria
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evaluated herein were: whether the study designs included in each
meta-analysis were clearly identified, whether natural disease
exposure trials and challenge trials (trials with deliberate induc-
tion of the outcome) were combined in the same meta-analysis,
whether observational and experimental data were combined in
a single meta-analysis, and whether at least one summary effect
measure was reported. This item and those subsequent items
that are specific to meta-analyses were only applied to those
reviews with a meta-analytic component.
The twelfth AMSTAR 2 domain was not evaluated in the
present analysis. This item requires either that meta-analyses
include only those primary studies at low risk for bias, or that
review authors undertake additional analyses to investigate and
discuss the potential impact that bias might have on the summary
effect measure. Framed in this way, this domain invites subjective
judgments about what level of analysis of the impact of bias is suf-
ficient. Further, this is a potentially controversial quality criterion
because the decision to exclude low-quality studies could be made
either during eligibility screening or after data extraction; if the
latter occurs, this may introduce reviewer subjectivity and poten-
tial bias (O’Connor and Sargeant, 2014). For the thirteenth item,
AMSTAR 2 requires review authors to account for the risk of bias
in individual primary studies in their interpretation of the results
of their review. Similar to item 12, the appropriate nature and
extent of this discussion are not elaborated in the AMSTAR 2
documentation, and so the application of this domain was consid-
ered to be ambiguous and subjective. Therefore, the present
analysis simply evaluated whether any studies were removed
from the review on the basis of the risk of bias assessment, and
reviews with no such exclusions were evaluated positively.
The fourteenth AMSTAR 2 item requires authors to explore
and explain any heterogeneity in the results of the review. This
item was considered fulfilled in the present analysis if the review
authors evaluated heterogeneity by using an I2 statistic for at least
on meta-analysis; since many of the reviews contained multiple
meta-analyses, it was not practical to evaluate discussions of
heterogeneity for each individual meta-analysis.
The penultimate AMSTAR 2 domain requires testing for small
studies effects, which are often used to assess publication bias, as
well as a discussion of the impact of any such bias on the review
results. For this criterion, we assessed whether reviews incorpo-
rated any graphical or statistical tests of small studies effects;
again, the number of individual meta-analyses precluded an
evaluation of any discussions of the impacts of publication biases
on the results of individual meta-analyses.
Finally, according to the sixteenth AMSTAR 2 domain, review
authors must identify their funding sources and/or other compet-
ing interests. This criterion was considered fulfilled herein if the
authors declared their source(s) of funding or specified that no
external funding was received.
Quality assessment
Network meta-analysis
In the event that a network or mixed-treatment effect
meta-analysis was identified for inclusion in the quality analysis,
additional alterations to the evaluation process would be required.
Network meta-analysis is a relatively new technique, which allows
for an assessment of the relative effects of multiple interventions
by synthesizing evidence across a network of trials (Cipriani et al.,
2013; Dias et al., 2013). Since network meta-analytic methods are
different from those methods employed in traditional (pairwise)
meta-analyses, the evaluation criteria that apply to traditional
meta-analyses might not be appropriate for assessing the quality
of a network meta-analysis. Therefore, any network meta-analyses
that were captured in this study were examined using only those
criteria that were not specific to meta-analyses (i.e. the
meta-analysis component of any such study was not assessed).
Identification of critical domains
Of the 16 items or domains in the AMSTAR 2 framework, the crea-
tors of the tool specify seven critical domains that can substantively
impact the validity of a systematic review. Briefly, these are: (i) a
protocol is registered a priori (Domain 2); (ii) an adequate literature
search is performed (Domain 4); (iii) justification is provided for
the exclusion of individual primary studies (Domain 7); (iv) risk
of bias is assessed for individual studies (Domain 9); (v) any
meta-analytic methods used are appropriate (Domain 11);
(vi) risk of bias is considered in the interpretation of the results
of the review (Domain 13); and (vii) publication bias is assessed
and the impact of any such bias is discussed (Domain 15). If one
of these domains is unsatisfactory, then the overall level of confi-
dence in the results of the review is considered to be ‘Low’ accord-
ing to AMSTAR 2; if more than one of the critical domains is
unsatisfactory, then the confidence level is considered to be
‘Critically Low’ (Shea et al., 2017). Each of these seven items was
assessed in turn to evaluate the quality of the reviews included in
this analysis.
Assessment of the seven AMSTAR critical domains
We generally followed the recommendations from the AMSTAR 2
tool for evaluating each review, with some modifications based on
expected practices in the animal health literature. Each of the
seven critical domains was assessed as follows:
(1) For the first domain, an article was characterized as a ‘Yes’ if
the authors indicated that an a priori protocol was developed,
and as a ‘No’ if the authors stated that no protocol was devel-
oped or if no information about an a priori protocol was
provided.
(2) For the second domain, articles were awarded a ‘Partial Yes’ if
at least two academic databases were searched, and if the
authors provided either key words for the search or the entire
search string used for at least one database; this was upgraded
to a ‘Yes’ if there was also an attempt to search the grey litera-
ture in some form, including examining conference proceed-
ings, contacting experts in the field, or searching industry
publications. In addition, in order to achieve a ‘Yes’ the
review authors must have searched the reference lists of all
included studies, and they must have stated the date at
which the database search of took place.
(3) The third critical domain received a ‘Partial Yes’ if the
authors stated the reasons for any article exclusions that
occurred during full-text screening, as well as the number
of articles that were excluded during full-text screening for
each of those reasons. Reviews received a ‘Yes’ for the third
domain if the authors provided a bibliography of all studies
excluded at full-text screening and if they identified the rea-
son for exclusion for each study listed in the bibliography.
(4) For the fourth critical domain, a ‘Partial Yes’ was assigned if
the authors stated that a risk of bias assessment was con-
ducted or if features of bias were incorporated into the eligi-
bility criteria (for example, if the review only examined
randomized or blinded trials), and a ‘Yes’ was awarded for
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the fourth domain if the tool used to conduct the risk of bias
assessment was also described; if neither of these conditions
was met, then a ‘No’ was indicated.
(5) Under the fifth domain, a ‘Partial Yes’ was awarded if a
meta-analysis was conducted, the study designs included in
the meta-analysis were identified, and neither natural expos-
ure and challenge trials nor experimental and observational
studies were combined in a single meta-analysis. A ‘Yes’
was indicated for this domain if, in addition to the ‘Partial
Yes’ conditions, an I2 value and a summary effect measure
were also reported as a part of at least one meta-analysis.
(6) The sixth critical domain, which requires review authors to
consider the impact of the risk of bias assessment on the
interpretation of their results, was not assessed in our study
because the criteria associated with this domain were deemed
to be subjective, ambiguous, or potentially inconsistent with
best practices for conducting systematic reviews (e.g. if studies
were excluded following the risk of bias assessment).
(7) Finally, articles were awarded a ‘Yes’ for the last critical domain
if an analysis of small study effects was reported; otherwise ‘No’
was recorded. If no meta-analysis was conducted, then both
the fifth and seventh critical domains were left blank and did
not affect the final quality assessment for those reviews. If
the article contained at least one meta-analysis but did not
explicitly use the systematic review label, then all of the critical
domains were assessed for that article.
Levels of confidence in the results of reviews
Following the evaluation of each of the seven critical domains as
well as the nine non-critical domains, researchers can then com-
bine those evaluations into an overall assessment of the confi-
dence that a reader should have in the results of the evaluated
review. Weaknesses, or unsatisfactory criteria, were divided into
those related to the critical domains, described above, and non-
critical weaknesses related to the other nine domains (Shea
et al., 2017) (see Table 2 for a complete list of AMSTAR 2
domains assessed in this study). In this study, a critical weakness
was identified if a review did not meet the criteria for one of the
six critical domains; a weakness was not assigned if a review met
or partially met the criteria. Each of the six domains was assessed
independently for each of the reviews, and the number of critical
weaknesses was evaluated for each individual review. A final con-
fidence rating was then assigned to each review based on the
number of critical weaknesses that were identified in the quality
assessment process.
The creators of the AMSTAR 2 tool suggest the following rating
for confidence in review results based on the evaluation of the
seven critical domains: (i) High Confidence: no or one non-critical
weakness; (ii) Moderate Confidence: more than one non-critical
weakness; (iii) Low Confidence: one critical weakness with or with-
out non-critical weaknesses; and (iv) Critically Low Confidence:
more than one critical weakness with or without non-critical
weaknesses (Shea et al., 2017). In the present analysis, only the
six relevant critical domains were assessed in depth for each review.
Since the distinction between ‘High Confidence’ and ‘Moderate
Confidence’ involves only the number of non-critical weaknesses,
these categories were combined under the heading ‘High/
Moderate Confidence’. For reviews that fell into this category, read-
ers may be relatively more confident that the review results provide
a complete, accurate synthesis of the existing literature compared to
those reviews in the ‘Low’ or ‘Critically Low’ confidence categories.
Results and discussion
Study characteristics
Figure 1 shows the flow of review articles through the screening
process. From the 1787 reviews identified in an earlier scoping
review (Vriezen et al., 2019), 1722 reviews were eliminated during
the abstract screening. Full texts were obtained for the remaining
65 reviews. Following the additional full-text screening, 38 reviews
were retained for inclusion in the quality assessment. The citation
Fig. 1. Flow chart of reviews throughout the screening process.
Chart illustrates the process of screening for eligibility of reviews
in the quality assessment of systematic reviews (SR) and
meta-analyses (MA) examining disease prevention interventions
or exposures in livestock.
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information for the 38 included reviews is available in
Supplementary Appendix 3.
Table 1 provides summary characteristics for the 38 reviews that
were eligible for inclusion in the quality assessment. The number
of systematic reviews and meta-analyses reviewing preventive
approaches to improve animal health has increased over time;
most (68.4%, n = 26/38) of the captured articles were published
after 2010, and only one review (2.6%) was published between
1995 and 1999. The majority of the reviews (57.9%, n = 22/38)
were meta-analyses that were conducted without specifying a corre-
sponding systematic review. Dairy and beef cattle were the most
common target commodity groups (39.8%, n = 15/38 and 31.6%,
n = 12/38, respectively). The majority of the reviews focused on
non-antibiotic management practices designed to reduce disease
incidence (78.9%, n = 30/38); relatively few reviews examined
preventive antibiotic use (13.2%, n = 5/38), and only three reviews
(7.9%) investigated both approaches.
The reviews contained a variety of intervention approaches.
Thirteen of the reviews incorporated antibiotic treatments; of
these, five reviews specified that antibiotic treatments were the
specific intervention under investigation, whereas the other eight
reviews evaluated management practices against control groups
including those treated with antibiotics. Vaccinations were the
most commonly studied intervention (n = 15). The outcomes
examined in the reviews varied, with mortality representing the
most commonly studied outcome (n = 26), followed by udder
health (n = 17) and reproductive outcomes including specific repro-
ductive morbidities, infertility, and abortion (n = 15). Other than
mastitis (captured under ‘udder health’), few reviews examined
interventions to reduce other infectious diseases (n = 3), digestive
morbidity (n = 2), or other clinical health outcomes such as lame-
ness (n = 3). One network meta-analysis was identified, which
reviewed applications of antibiotics to prevent morbidity and mor-
tality due to respiratory disease in beef cattle (Abell et al., 2017).
Quality assessment
Table 2 lists each of the AMSTAR 2 items considered in the qual-
ity analysis, alongside the specific criteria used to evaluate each
item. The table shows the number and percentage of review
articles that met each criterion, as well as the percentage of
meta-analyses that met each criterion, as appropriate.
Most of the 38 review articles (92.1%, n = 35) incorporated all
of the PICO/PECO elements in the review question, objectives, or
Table 1. Summary characteristics of 38 systematic reviews and/or





















Layer hens, Eggs 1
Turkeys 1
Poultry, unspecified 3
Approach to disease reduction
Preventative antibiotic use 5
























aNetwork meta-analyses were assessed in the same manner as systematic reviews.
bMay sum to more than the total number of reviews, as reviews may have examined more
than one species.
cMay sum to more than the total number of reviews, as reviews may have examined more
than one intervention.
dIncludes review articles in which antibiotics were used in control groups.
eIncludes vitamins, probiotics, and yeast cell-wall products.
fIncludes changes in housing practices and variations in dry period length.
gMay sum to more than the total number of reviews, as reviews may have examined more
than one outcome.
hIncludes lameness.
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Table 2. Summary of quality assessment criteria for 38 systematic reviews and/or meta-analyses examining preventative approaches to reducing antibiotic use





1. Did the research questions and inclusion criteria for the
review include the components of PICO?
Research question included all of the
elements of PICOa
35 92.1
Explicit eligibility criteria were
provided
32 84.2
2. Did the report of the review contain an explicit statement
that the review methods were established prior to the
conduct of the review and did the report justify any
significant deviations from the protocol?
An a priori protocol was developed 6 15.8
3. Did the review authors explain their selection of the study
designs for inclusion in the review?
Eligible study designs were identified
in the searchb
15 39.5
Eligible study designs were identified
during data extraction
30 78.9
4. Did the review authors use a comprehensive literature
search strategy?
Method for literature search described 29 76.3
Search string or key words were
provided
23 60.5
At least two electronic databases were
searched
28 73.7
Searched the reference lists of
included studies
15 39.5
Some attempt was made to search the
grey literature
14 36.8
Eligible languages were identified in
the searchc
23 60.5
Provided date of search 16 42.1
5. Did the review authors perform study selection in
duplicate?
Study selection was performed in
duplicate
10 26.3
6. Did the review authors perform data extraction in
duplicate?
Data extraction was conducted in
duplicated
6 15.8
7. Did the review authors provide a list of excluded studies
and justify the exclusions?
Reasons for exclusions and numbers of
studies excluded for each reason were
providede
15 39.5
A bibliography and reasons for
exclusion for each study were
providedf
4 10.5
8. Did the review authors describe the included studies in
adequate detail?
Languages of included studies were
identified
15 39.5
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9. Did the review authors use a satisfactory technique for
assessing the risk of bias (RoB) in individual studies that
were included in the review?
A formal RoB assessment was
conductedg
20 52.6
The tool used to conduct the RoB
analysis was identified
8 40.0h
RoB assessment was conducted in
duplicate
4 20.0i
11. If meta-analysis was performed did the review authors
use appropriate methods for statistical combination of
results?
A meta-analysis was performedj 33 86.8 100.0
Study designs included in the
meta-analysis were identified
29 76.3 87.9
Natural disease exposure and




designs were not combined in the
same meta-analysis
29 100.0l
At least one summary effect measure
was reported
13 34.2 39.4
13. Did the review authors account for RoB in individual
studies when interpreting/discussing the results of the
review?
No exclusions were made on the basis
of RoB assessmentm
37 97.4
14. Did the review authors provide a satisfactory explanation
for, and discussion of, any heterogeneity observed in the
results of the review?
At least one I-squared value was
reported
23 60.5 69.7
15. If they performed quantitative synthesis did the review
authors carry out an adequate investigation of publication
bias (small study bias) and discuss its likely impact on the
results of the review?
Publication bias (small study effects)
was assessed
13 34.2 39.4
16. Did the review authors report any potential sources of
conflict of interest, including any funding they received for
conducting the review?
Funding source(s) were declaredn 16 42.1
aPICO = Population (P), Intervention (I), Comparator (C), Outcome (O).
bReviews were also included if the authors specified that no restrictions were placed on study designs eligible in the search.
cReviews were also included if the authors specified that no restrictions were placed on languages eligible in the search.
dReviews were included if data extraction was conducted by two independent reviewers, or if data extraction was performed by one reviewer and verified by a second reviewer.
eReasons were only required for exclusions made during full-text screening. Reviews were also included if they explicitly stated that no exclusions were made during full-text screening.
fBibliographic references and reasons were only required for exclusions made during full-text screening. Reviews were also included if they explicitly stated that no exclusions were made
during full-text screening.
gReviews were included if a formal assessment was conducted or if features of bias were included in the eligibility criteria (e.g. the review was limited to randomized trials).
h% of risk of bias assessments (n = 8/20).
i% of risk of bias assessments (n = 4/20).
jExcludes network meta-analyses.
k% of meta-analyses in which the included study designs were reported (n = 22/29).
l% of meta-analyses in which the included study designs were reported (n = 29/29).
mReviews were included if the authors specified that no exclusions were made on the basis of the risk of bias assessment, or if no information was provided about exclusions resulting from
the risk of bias assessment.
nReviews were included if the funding source was declared or if the authors specified that the review received no external funding.
312 Rachael Vriezen et al.
inclusion criteria, and most (84.2%, n = 32) explicitly identified
eligibility criteria for the primary studies included in the review.
A clearly specified review question is important because it ensures
that it is possible to design a search and screening process that will
capture all relevant studies, and hence reduces the potential for
selection bias (O’Connor et al., 2014; Sargeant and O’Connor,
2014a). Only 15.8% (n = 6) of reviews indicated that an a priori
protocol was developed. The development of a review protocol
is essential to minimize bias and promote transparency in the
review process. If authors are aware of the findings of potentially
relevant primary studies, these results may influence the final
wording of the review question, the choice of eligibility criteria,
and the identification of interventions and outcomes of interest;
a protocol minimizes the risk of bias towards primary studies
with specific results by establishing key decisions about the
focus and methods of the review in advance (Higgins and
Green, 2011).
Nearly 80% (n = 30) of the reviews identified the study designs
that were eligible for data extraction, and 39.5% (n = 15) stated
whether or not restrictions were placed on the study designs
that were eligible during the search. Different types of studies
(e.g. experimental versus observational studies) may be appropri-
ate in different situations or for different research questions.
According to the creators of AMSTAR 2, it is critical that review
authors justify the inclusion of different study designs in their
review (Shea et al., 2017). If eligible study designs are not specified
in the search but are specified later (i.e. once the authors have
viewed the full-text publications during data extraction), this
introduces another potential source of bias; for example, authors
may only select and analyze those studies and study designs that
reflect their pre-conceived ideas about the results and their rele-
vance to the review question. Specifying eligible study designs
prior to full-text screening or data extraction may help to mitigate
this potential bias.
Three-quarters of the reviews (76.3%, n = 29) included a
description of the methods used to search for relevant literature,
which implies that one-quarter of review authors did not describe
their search methods. Without a clear description of the search
procedures, the review methods are neither transparent nor repro-
ducible, both of which are crucial foundations of the systematic
review process (Higgins and Green, 2011). Approximately 40%
(n = 15) of the included reviews specified that the reference lists
of all eligible primary studies were searched in an effort to identify
other potentially relevant studies. Additionally, less than half of
the captured review studies (36.8%, n = 14) attempted to search
the grey literature, which includes conference proceedings, indus-
try reports, and contact with experts in the field. Failing to search
the grey literature might mean that the review authors missed
some primary studies or other information that is relevant to
the review question. In particular, identifying and including com-
pleted but unpublished studies may help to reduce bias since there
are often systematic differences between those studies that are
published in full and those that are completed but unpublished
(e.g. studies with positive results or larger sample sizes are more
likely to be published) (Higgins and Green, 2011; Scherer et al.,
2018). Finally, 42.1% (n = 16) of the reviews identified the date
of the literature search. For reviews that did not specify the date
of the search, readers cannot be certain of the date after which
published studies would not be included in the review.
Only one-quarter of reviews (26.3%, n = 10) explicitly stated
that the selection of primary studies for inclusion in the review
was conducted in duplicate, and fewer (15.8%, n = 6) reported
that data extraction was conducted in duplicate. For those reviews
that did not indicate that these steps were conducted in duplicate,
it was often impossible to determine whether study selection and
data extraction were truly conducted by a single individual, or
whether the reviewers failed to report that these steps were con-
ducted in duplicate. By their nature, decisions regarding which
studies to include and the interpretations of some forms of pri-
mary data during the review process may involve some subjective
judgments. Conducting these steps in duplicate (i.e. by more than
one reviewer) helps to reduce subjectivity and ensure that these
decisions are reproducible. In addition, conducting study selection
and data extraction in duplicate can help to ensure that no rele-
vant studies are inadvertently rejected, may minimize errors in
the extraction process, and may also reduce the impact of any
biases based on an author’s pre-formed opinions or prior experi-
ences that might impact their evaluation of the validity and rele-
vance of particular studies or data points (Higgins and Green,
2011).
Once the review authors have viewed the data contained within
a primary study, the decision on whether to include or exclude the
study may be subject to bias. It may be necessary to exclude some
studies after the full text has been obtained (e.g. if the answers to
some screening questions were unclear based on the title and
abstract alone); however, in such cases, it is recommended that
authors identify the reasons for exclusions to minimize the poten-
tial for bias due to exclusion decisions (O’Connor and Sargeant,
2014; Sargeant and O’Connor, 2014b; Viswanathan et al., 2018).
Reasons for exclusions made after the full text was retrieved, as
well as the numbers of studies that were excluded for each reason,
were provided in 40% (n = 15) of the included reviews. A smaller
number of reviews (10.5%, n = 4) provided a bibliography of those
studies excluded during or after full-text screening and identified
the specific justification for exclusion for each study.
Risk of bias assessments is a crucial component of systematic
reviews, as these assessments provide an evaluation of the validity
of the results of the primary studies included in the review
(Higgins and Green, 2011). If the results of the primary studies
included in the review are biased, then the summary conclusions
of the review may be similarly biased. If reviews do not include an
assessment of the risk of bias of the primary studies, then
end-users of the review results will not be able to judge the poten-
tial for bias. Approximately half (52.6%, n = 20) of the reviews in
this study conducted some form of risk of bias assessment. Of
these, 40% (n = 8/20) identified the tool used to conduct the
assessment, and 20% (n = 4/20) stated that the assessment was
conducted in duplicate. Identifying the risk of bias tool is essential
for readers to judge the appropriateness of the assessment meth-
ods, and conducting the assessment in duplicate can help to
reduce reviewer biases in the evaluation process.
Thirty-three reviews included at least one pairwisemeta-analysis.
The study designs that were included in the meta-analysis were
identified in most of the reviews (87.9%, n = 29/33). None of the
reviews combined observational and experimental study designs
in the same meta-analysis; review results may be misleading if
researchers combine effects from different study designs into one
summary measure, particularly if study design is not being exam-
ined as a source of heterogeneity in the meta-analysis (Higgins and
Green, 2011; O’Connor and Sargeant, 2014). Of the meta-analyses
in this study, both natural exposure and challenge trials were com-
bined in at least one meta-analysis in 21% (n = 7/33) of the reviews.
Trials with natural disease exposure and challenge trials may not be
comparable as disease challenge may not reflect natural disease
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exposure conditions or implications, and these trials are often con-
ducted in more highly controlled settings (Sargeant et al., 2014a,
2014b). As a result, combining data from both types of trials may
result in summary effect measures that are not indicative of the
true effects of interventions under natural exposure conditions.
In addition, 40% (n = 13/33) of the publications that included
a meta-analysis reported at least one summary effect measure. A
summary effect measure is a single point estimate that combines
the effects and associated uncertainty measures from each of the
individual primary studies included in the meta-analysis
(O’Connor and Sargeant, 2014). The goal of meta-analysis often
provides a precise estimate of the effect of a given intervention
on a given outcome, and a summary effect measure is a tool by
which this is achieved (O’Connor et al., 2014). If a summary effect
measure is not reported, then the reader of the meta-analysis has
no indicator of the pooled impact of the intervention(s) being
examined on the outcome(s) of interest. However, if heterogeneity
is large, the summary effect may be misleading; thus, it is not
always appropriate to report a summary measure. Evaluating
whether or not summary effect measure reporting was appropri-
ate given the amount of heterogeneity in each meta-analysis was
beyond the scope of the current review.
Alternatively or in addition to the generation of a summary
effect measure, a meta-analysis may evaluate sources of hetero-
geneity (i.e. the reasons why different studies report different
results) (O’Connor et al., 2014). Some authors contend that a
meta-analysis should always include an evaluation of heterogen-
eity, with or without the calculation of a summary effect measure
(O’Connor and Sargeant, 2014). More (70%, n = 23/33) of the
meta-analyses in this study included an exploration of heterogen-
eity (expressed as an I2 value). However, ten of the papers that
included a meta-analytic component (30.3%) did not present
either a summary effect measure or an I2 value for any of the
meta-analyses included in the review. In these cases, the purpose
of undertaking a meta-analysis was therefore unclear.
Finally, 40% (n = 13/33) of the meta-analyses included an
investigation into publication bias. Publication bias occurs when
the published research on a topic is not representative of all com-
pleted studies on that topic for a variety of reasons, including but
not limited to: outcome bias (reporting of the results, and the
selection of results for reporting, of a primary study and the will-
ingness of journal editors to publish those results, depends on the
direction and statistical significance of those results); bias related
to study size (large studies are more likely to detect statistically
significant relationships than small studies and small studies are
more likely to be published if they report statistically significant
findings); duplication bias (some findings may be published
multiple times, or may be suppressed if they are not novel); and
competing interest bias (results may be selectively published
based on the financial, political, or professional interests of
researchers, funding agencies, journal editors, and others)
(Rothstein, 2008; Higgins and Green, 2011). Where publication
bias exists, the results of review studies may not be truly reflective
of the existing body of research on the review topic. If publication
bias is not investigated, readers of the review cannot evaluate the
impact that any such bias may have on the results of the review.
However, it should be noted that it is not always feasible to evalu-
ate publication bias, particularly if the number of studies included
in the meta-analysis is low; generally, at least ten primary studies
must be included in a meta-analysis in order for statistical tests
for publication bias to be meaningful (Sterne et al., 2000;
Ioannidis and Trikalinos, 2007). Determining whether or not
the meta-analyses in each of the reviews incorporated a sufficient
number of studies to support an assessment of publication bias
was beyond the scope of the present study.
Funding source(s) were declared by the authors in less than
half of the reviews (42.1%, n = 16). The source of funding for
any academic study could potentially introduce a source of bias,
depending on the interests of the funding body (Bero, 2013;
Lundh et al., 2017). It should be noted that the empirical evidence
concerning funding and bias is based on the human health litera-
ture, and the relationship between funding sources and the poten-
tial for bias has not been assessed in the animal health literature.
However, the Preferred Reporting Items for Systematic reviews
and Meta-Analyses (PRISMA) guidelines for the reporting of sys-
tematic reviews recommend that review authors report funding
sources and the role(s) that funders played in the review process
if any; this helps to ensure that the review process is transparent
(Liberati et al., 2009). Providing this information allows the reader
to judge the potential for any such bias, and so failing to disclose
funding information generates uncertainty about the validity of
the results, thus lowering the reader’s confidence in the results
of the review.
Table 3 shows the number and percentage of reviews that met,
partially met, or did not meet the criteria for each of the six
AMSTAR 2 critical domains that were evaluated in this study.
The table also includes a summary of the final quality assessment
for the included reviews. According to the creators of the
AMSTAR 2 tool, a weakness in any of these critical domains
has serious implications for the validity of the results of a review
(Shea et al., 2017). When these six domains were evaluated for
each review article, only three articles (7.9%) did not have any
critical weaknesses (Ariza et al., 2017; Nautrup et al., 2017;
Naqvi et al., 2018). A further three reviews (7.9%) had one critical
weakness, or failed to meet the criteria for one of the critical
domains; these were classified as ‘Low Confidence’. Finally, nearly
85% of the review articles (n = 32) failed under multiple critical
domains, indicating that readers should have ‘Critically Low
Confidence’ in the results of those reviews. Readers of these
reviews must use caution when interpreting and applying results
because these reviews may not provide an accurate, comprehen-
sive synthesis of the existing body of literature (Shea et al., 2017).
A concern is the number of meta-analyses that were undertaken
without a corresponding systematic review. Two-thirds of the
meta-analyses captured in the present review (66.7%, n = 22/33)
were conducted without a corresponding systematic review compo-
nent. Conducting a systematic review to inform the meta-analysis
ensures that the data identification and collection process is
transparent and comprehensive (Sargeant and O’Connor, 2016;
O’Connor et al., 2014, 2014a). Additionally, the risk of bias assess-
ment component of a systematic review provides insight into the
quality of the results of the primary studies, which may, in turn,
impact the results of the meta-analysis (Sargeant and O’Connor,
2016). In this study, a larger proportion of meta-analyses that
were conducted as a part of a broader systematic review had higher
quality ratings than those reviews that presented a meta-analysis
alone. Of those meta-analyses conducted without a supporting
systematic review, only one rated ‘High/Moderate Confidence’,
one rated ‘Low Confidence’, and 90.9% (n = 20/22) fell into the
‘Critically Low Confidence’ category. Of those studies that incorpo-
rated both a systematic review and a meta-analysis component, two
received a ‘High/Moderate Confidence’ rating, and nine received
a ‘Critically Low Confidence’ rating (81.8%, n = 9/11). When
meta-analyses were conducted without a corresponding systematic
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review, a larger proportion failed to fulfill the criteria for some of
the critical domains. For example, 59.1% (n = 13/22) of the
meta-analyses that did not involve a systematic review did not
incorporate an adequate search strategy; for those meta-analyses
that were supported by a systematic review, this percentage was
only 18.2% (n = 2/11). Similarly, 63.6% (n = 14/22) of the unsup-
ported meta-analyses failed to adequately assess the risk of bias,
whereas only 27.3% of the combined systematic review/
meta-analysis studies failed to meet this criterion. The evidence
from our review supports the conclusion that meta-analyses should
be conducted alongside a systematic review. However, there is
room for improvement in the methodological quality of both sys-
tematic reviews and meta-analyses to ensure that they are valid
sources of information for informed decision-making.
Additional considerations
In order to minimize the impact of publication bias and to ensure
comprehensive coverage of the existing literature, the literature
search components of systematic reviews should be extensive
(Glanville et al., 2013). Based on the AMSTAR 2 criteria, only
11 reviews (28.9%) incorporated a satisfactory literature search
strategy. Within those reviews that reported at least some detail
of their search, the number and types of databases searched varied
considerably. Searching multiple sources increases the likelihood
of retrieving all relevant records, but there is no consensus as to
the correct number of databases that should be examined. The
actual number of databases searched should depend on the nature
of the review question, as well as time and budget constraints
(Glanville et al., 2013). For those articles that identified at least
one database, the number of databases searched ranged from 1
to 14. The most commonly searched databases were MEDLINE
via PubMed or other platforms, which was searched in 28 reviews
(73.7%), followed by CABI or CAB Direct (60.5%, n = 23),
AGRICOLA (31.6%, n = 12), Web of Science (23.7%, n = 9),
Scopus (15.8%, n = 6), and Google Scholar (13.2%, n = 5).
Thirty-five additional sources of published literature were identi-
fied in various reviews, each of which was searched in a small
number of reviews (one, two, or three reviews). Some research
questions require searches of more specialized information
sources, such as LILACS, which covers medical journals from
Latin America and the Caribbean (Glanville et al., 2013), and
was searched in one of the included reviews. Similarly, a wide
range of grey literature sources was searched (16 different
sources), the most common of which were pharmaceutical
sources (21.1%, n = 8), conference proceedings (18.4%, n = 7),
and contacting experts in the field (7.9%, n = 3).
The authors of the Cochrane Handbook identify three data-
bases that they argue are the most important sources of primary
studies for inclusion in Cochrane systematic reviews of human
healthcare interventions: CENTRAL, MEDLINE, and EMBASE
(now Embase) (Higgins and Green, 2011). Since the CENTRAL
(Cochrane Controlled Register of Trials) database contains pri-
marily randomized controlled trials in human medical research,
this is not likely to be an appropriate source for the reviews cap-
tured in this study. MEDLINE was the most commonly searched
database across the reviews in the present study (n = 28, 73.7%).
Two reviews (5.3%) searched Embase. Although the databases
recommended for reviews on human health topics may also con-
tain some articles that are relevant to animal health, such data-
bases may not be the most appropriate or useful sources to
search for animal health reviews. In veterinary medicine, an inves-
tigation into the databases containing the best coverage of an
extensive list of veterinary journals revealed that CAB Abstracts
Table 3. AMSTAR 2 seven critical quality assessment domains applied to 38 systematic reviews and/or meta-analyses examining preventative approaches to
reducing antibiotic use
Yes Partial Yes No
Number % Number % Number %
Did the report of the review contain an explicit statement that the review methods
were established prior to the conduct of the review and did the report justify any
significant deviations from the protocol?
6 15.8 32 84.2
Did the review authors use a comprehensive literature search strategy? 3 7.9 19 50.0 16 42.1
Did the review authors provide a list of excluded studies and justify the exclusions? 3 7.9 11 28.9 24 63.2
Did the review authors use a satisfactory technique for assessing the risk of bias
(RoB) in individual studies that were included in the review?
8 21.1 12 31.6 18 47.4
If meta-analysis was performed did the review authors use appropriate methods for
statistical combination of results?a
11 33.3 12 36.4 10 30.3
If they performed quantitative synthesis did the review authors carry out an
adequate investigation of publication bias (small study bias) and discuss its likely
impact on the results of the review?a
13 39.4 20 60.6
Number %
Final quality assessment
High/Moderate confidence 3 7.9
Low confidence 3 7.9
Critically low confidence 32 84.2
aThis domain was only applied to those reviews in which a meta-analysis was performed. If a meta-analysis was not performed, this domain was not assessed and the score for this domain
was not considered in the final quality assessment.
Animal Health Research Reviews 315
had the most extensive coverage (90.2%) (Grindlay et al., 2012). In
addition, CAB Abstracts indexed the highest number of unique
journals. The authors of that study concluded that CAB
Abstracts should be included in all searches designed to locate
all published evidence on any veterinary topic and that the add-
ition of other databases (Scopus, Science Citation Index/Web of
Science, BIOSIS Previews, and Zoological Record) would slightly
increase journal coverage. They further concluded that MEDLINE
or Embase alone cannot be relied upon to provide comprehensive
coverage of the animal health literature (Grindlay et al., 2012). Of
the reviews captured in this study, 60.5% (n = 23) included CAB
or CAB Direct in the search strategy, which implies that 40% of
reviews did not. Those reviews that did not search CAB via
CAB Direct or another platform may have missed relevant studies
that were published in journals that were only indexed in that
database.
Limitations
The quality assessment framework used in this study was based
on the AMSTAR 2 critical appraisal tool. There were some chal-
lenges associated with the use of this tool to assess the quality of
systematic reviews and meta-analyses in animal health literature.
Some of the items were difficult to adapt for the present analysis
due to the differences between human and animal health research;
for instance, item nine on the AMSTAR 2 checklist details the fea-
tures of an appropriate risk of bias assessment for synthesis stud-
ies in the human medical literature, but some of the components
of human healthcare bias assessments may not be relevant in
studies of animal health. For example, in confined livestock popu-
lations such as beef cattle, swine, and poultry, in which the
animals are housed in groups, all animals are typically enrolled
in a trial and the differential economic value of each animal
may not be known at the time of allocation to treatment groups.
As such, evaluating whether concealment occurred during the
allocation process may not be relevant to a broader risk of bias
assessment (Moura et al., 2019).
The number of meta-analyses presented in some of the reviews
also made it difficult to apply the AMSTAR 2 criteria, as several of
these criteria require detailed information about and evaluations
of components of each individual meta-analysis. Two of the
items on the AMSTAR 2 tool (items 12 and 13) suggest that
authors include only randomized controlled trials with a low
risk of bias in a meta-analysis or that authors include some
form of discussion about the potential impact of including higher
risk of bias studies. The tool does not include an elaboration on
the appropriate features that such a discussion should include,
and so an objective evaluation of these criteria is difficult. If
authors choose to include only studies at low risk of bias, this
decision must be made a priori and not following the risk of
bias assessment; once trials have been assessed for risk of bias,
deciding to include or exclude a trial on the basis of that assess-
ment may introduce bias into the meta-analysis. The AMSTAR
2 tool does not provide an indication of the stage of the review
process at which the decision to include studies based on features
of bias must be made. As a result, these items were not evaluated
according to the AMSTAR 2 criteria in the present study.
Additionally, the AMSTAR 2 tool allocates the same weight to
all items on the assessment checklist, which may not be appropri-
ate. The identification of the seven critical domains is useful, but
these domains are not clearly indicated within the AMSTAR 2
checklist itself, and no weighting scheme is suggested beyond
the confidence level ratings. Further, some elements required by
the AMSTAR 2 checklist do not seem to be particularly useful
or relevant to the quality assessment of systematic reviews. For
example, the fourth item on the AMSTAR 2 checklist, which
details the criteria for an appropriate literature search, requires
that review authors search the reference lists and bibliographies
of all included primary studies in an effort to locate additional
relevant studies. This is a time-consuming process and may
yield few results. For example, in their review of antibiotics
used to control bovine respiratory disease, Nautrup et al. (2017)
identified only three citations in their hand search of the reference
lists of relevant studies, compared to the 707 citations that were
identified through database searches (Nautrup et al., 2017). In
another animal health-related review, Theurer et al. (2015)
found 1751 citations when they combined their search terms
and applied them to three online databases, but they only identi-
fied one additional study by manually searching reference lists
(Theurer et al., 2015); similarly, Larson and Step (2012) identified
703 potentially relevant studies through database searches but
identified only four studies by hand-searching bibliographies
(Larson and Step, 2012). That same checklist item requires the
search to be conducted within 24 months of the completion of
the review. However, determining the date of the completion of
a review can be difficult, as the date at which academic papers
are submitted for publication is seldom made available, and
submission, peer review, and other steps that are a part of the
publishing process can vary in duration.
Finally, some items on the AMSTAR 2 checklist are more rele-
vant to the completeness of reporting, as opposed to methodo-
logical quality. Specifically, items 1, 8, 10, and 16 concern the
reporting of the review research question, details of the studies
included in the review, funding sources for the included studies,
and sources of funding for the review, respectively. Although
clear, comprehensive is essential, research quality and research
reporting are separate issues. Comprehensive reporting guidelines
for synthesis research are currently available elsewhere, such as
PRISMA (Liberati et al., 2009).
Other quality assessment tools for synthesis research exist. For
instance, the European Food Safety Authority (EFSA) developed a
critical appraisal tool to evaluate the quality of systematic reviews
of intervention studies. Similar to the AMSTAR 2 tool, the EFSA
framework lists appraisal questions related to important steps of
the systematic review process, such as ‘Was the extensive literature
search performed in an appropriate way?’ and ‘Were preventive
steps taken to minimise bias and errors in the study selection
process?’ (EFSA, 2015). Each appraisal question is presented
alongside a list of criteria to consider when evaluating each
item, and space is provided to summarize the information pre-
sented in the review and to justify the final appraisal for each
item in the tool. The actual appraisal is conducted on a four-point
scale from ‘Definitely appropriate’ to ‘Definitely not appropriate’,
with an additional ‘Not Applicable’ option (EFSA, 2015).
However, this evaluation system does require subjective judg-
ments about the adequacy of each element, and therefore the
results of an evaluation based on this tool may not be reprodu-
cible. In the AMSTAR 2 framework, the criteria for appraisal
are arguably more objective. For example, in applying the
AMSTAR 2 checklist, the evaluator determines if more than
two databases were searched and if the search string was provided,
whereas the EFSA tool requires the evaluator to make a subjective
determination as to whether ‘too many’ search concepts were used
(EFSA, 2015).
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AMSTAR 2 was developed for evaluations of systematic
reviews related to human health. Much of the framework can
be adapted for evaluating reviews of animal health topics, and
the tool provides valuable insight into the strengths and weak-
nesses of review studies in general. An empirical investigation
into those elements of the research process that specifically impact
the results of systematic reviews in animal health may help to fur-
ther refine quality assessment frameworks for applications in ani-
mal health research.
Conclusion
Thirty-eight reviews examining a broad range of commodity
groups, interventions, and outcomes were identified for inclusion
in this analysis. Based on our application of the AMSTAR 2 frame-
work (Shea et al., 2017), the quality of most of the systematic
reviews and meta-analyses on preventive approaches to disease
reduction is critically low, which implies that decision-makers
must use caution when relying on the results of these reviews.
Although there were challenges associated with the use of the
AMSTAR 2 tool in this analysis, the AMSTAR 2 framework
represents a comprehensive and objective tool available for the
evaluation of systematic reviews and meta-analyses. An empirical
investigation into which elements of quality assessment tools are
most relevant to synthesis research evaluations in the animal health
field may provide important insights for the continuing refinement
of quality assessment frameworks and their applications for animal
health research.
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